RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CSPC Pharmaceutical Group Stock

CSPC Pharmaceutical Group ROE 2024

CSPC Pharmaceutical Group ROE

0.18

Ticker

1093.HK

ISIN

HK1093012172

WKN

548183

In 2024, CSPC Pharmaceutical Group's return on equity (ROE) was 0.18, a -12.31% increase from the 0.2 ROE in the previous year.

CSPC Pharmaceutical Group Aktienanalyse

What does CSPC Pharmaceutical Group do?

CSPC Pharmaceutical Group Ltd. is a leading pharmaceutical company in China. It was founded in 1997 and specializes in the manufacturing of pharmaceutical raw materials, intermediates, and finished drugs. The company's product range covers various therapy areas and provides a variety of medications for patients worldwide. The company's business model is based on research, development, and production of pharmaceutical products for the mass market. In 2019, CSPC Pharmaceutical achieved a revenue of 9.9 billion USD. The company's products are represented in 24 countries worldwide and aim to improve people's lives through innovations in the healthcare sector. CSPC Pharmaceutical has various divisions, including its sister company CSPC Zhongqi Pharmaceutical Technology Co. Ltd., which specializes in innovative technologies for drug manufacturing. Other divisions include CSPC Weisheng Pharmaceutical Co. Ltd. for marketing and distribution in China, as well as CSPC Ouyi Pharmaceutical Co. Ltd. for the production of traditional Chinese medicines. The product range of CSPC Pharmaceutical is diverse and offers medications for various application areas. This includes cancer therapy with products such as Anastrozole tablets and Vinorelbine injection solution. In the field of cardiovascular diseases, CSPC Pharmaceutical offers Metoprolol Succinate tablets. Additionally, the company provides products for the treatment of pain and inflammation, such as Ibuprofen suspension and generic versions of Celecoxib. Another focus of the company is the research and production of antibiotics, which are important medications in the treatment of bacterial infections. CSPC Pharmaceutical produces a wide range of antibiotics in different dosage forms, including Cefazolin Sodium injection solutions and Cefalotin Sodium injection solutions. Throughout its history, CSPC Pharmaceutical has received various awards and certifications that confirm the high quality of its products. In 2019, the company was honored as the "Best Innovative Pharmaceutical Firm" at the Asia-Pacific Biotech Industry Awards. Furthermore, CSPC Pharmaceutical has obtained the ISO 9001:2015 Quality Management System certificate, and its products are approved by the US FDA, the European Medicines Agency, and the National Medical Products Administration in China. Overall, CSPC Pharmaceutical is an important player in the Chinese pharmaceutical market, offering a wide product range and increasing the level of innovation through research and development. With its continuous growth and efforts towards quality and innovation, CSPC Pharmaceutical will continue to play a significant role in the global healthcare market. CSPC Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding CSPC Pharmaceutical Group's Return on Equity (ROE)

CSPC Pharmaceutical Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing CSPC Pharmaceutical Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

CSPC Pharmaceutical Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in CSPC Pharmaceutical Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about CSPC Pharmaceutical Group stock

What is the ROE (Return on Equity) of CSPC Pharmaceutical Group this year?

The ROE of CSPC Pharmaceutical Group this year is 0.18 undefined.

How has the Return on Equity (ROE) of CSPC Pharmaceutical Group developed compared to the previous year?

The ROE of CSPC Pharmaceutical Group has increased by -12.31% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of CSPC Pharmaceutical Group?

A high ROE indicates that CSPC Pharmaceutical Group generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of CSPC Pharmaceutical Group?

A low ROE can indicate that CSPC Pharmaceutical Group is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of CSPC Pharmaceutical Group affect the company?

A change in ROE (Return on Equity) of CSPC Pharmaceutical Group can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of CSPC Pharmaceutical Group?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of CSPC Pharmaceutical Group?

Some factors that can influence CSPC Pharmaceutical Group's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does CSPC Pharmaceutical Group pay?

Over the past 12 months, CSPC Pharmaceutical Group paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 4.58 %. For the coming 12 months, CSPC Pharmaceutical Group is expected to pay a dividend of 0.28 CNY.

What is the dividend yield of CSPC Pharmaceutical Group?

The current dividend yield of CSPC Pharmaceutical Group is 4.58 %.

When does CSPC Pharmaceutical Group pay dividends?

CSPC Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of October, June, July, November.

How secure is the dividend of CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group paid dividends every year for the past 17 years.

What is the dividend of CSPC Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.28 CNY are expected. This corresponds to a dividend yield of 5.15 %.

In which sector is CSPC Pharmaceutical Group located?

CSPC Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSPC Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSPC Pharmaceutical Group from 11/20/2024 amounting to 0.16 CNY, you needed to have the stock in your portfolio before the ex-date on 10/31/2024.

When did CSPC Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of CSPC Pharmaceutical Group in the year 2023?

In the year 2023, CSPC Pharmaceutical Group distributed 0.2 CNY as dividends.

In which currency does CSPC Pharmaceutical Group pay out the dividend?

The dividends of CSPC Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CSPC Pharmaceutical Group

Our stock analysis for CSPC Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSPC Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.